(Total Views: 99)
Posted On: 09/12/2023 12:20:48 PM
Post# of 124252
$ALT News Article - Altimmune Announces Completion of Dosing in the Phase 2 MOMENTUM Trial of Pemvidutide in Subjects with Obesity or Overweight https://marketwirenews.com/news-releases/alti...02536.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
